Tyche Industries [TYCHE] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Tyche Industries Ltd. wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 1 ties. Tyche Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Tyche Industries Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.41 | 73.73 | Tyche Industries Ltd. |
| Price-to-Book Ratio | 0.89 | 13.36 | Tyche Industries Ltd. |
| Debt-to-Equity Ratio | 0.00 | 27.04 | Tie |
| PEG Ratio | -0.30 | -17.55 | Tyche Industries Ltd. |
| EV/EBITDA | 27.30 | 52.76 | Tyche Industries Ltd. |
| Profit Margin (TTM) | 13.29% | 29.99% | Gujarat Themis Biosyn Ltd. |
| Operating Margin (TTM) | 5.74% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 5.74% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 9.08% | 19.64% | Gujarat Themis Biosyn Ltd. |
| Return on Assets (TTM) | 8.42% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $78.21M | $-251.22M | Tyche Industries Ltd. |
| Dividend Yield | 3.84% | 0.17% | Tyche Industries Ltd. |
| 1-Year Return | -8.25% | 15.75% | Gujarat Themis Biosyn Ltd. |
| Price-to-Sales Ratio (TTM) | 2.48 | 22.23 | Tyche Industries Ltd. |
| Enterprise Value | $982.33M | $36.09B | Gujarat Themis Biosyn Ltd. |
| EV/Revenue Ratio | 1.94 | 22.65 | Tyche Industries Ltd. |
| Gross Profit Margin (TTM) | 75.49% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $49 | $15 | Tyche Industries Ltd. |
| Earnings per Share (Diluted) | $6.65 | $4.40 | Tyche Industries Ltd. |
| Beta (Stock Volatility) | 0.29 | -0.17 | Gujarat Themis Biosyn Ltd. |
Tyche Industries Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Tyche Industries Ltd. | -0.24% | -0.75% | -6.47% | 17.94% | 6.30% | 9.52% |
| Gujarat Themis Biosyn Ltd. | -0.57% | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Tyche Industries Ltd. | -8.25% | -33.38% | -41.08% | 102.47% | 785.21% | 449.13% |
| Gujarat Themis Biosyn Ltd. | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
Performance & Financial Health Analysis: Tyche Industries Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | TYCHE | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.25B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,314 | 79,452 |
| 90 Day Avg. Volume | 8,883 | 106,446 |
| Last Close | ₹126.55 | ₹385.10 |
| 52 Week Range | ₹99.00 - ₹148.80 | ₹225.05 - ₹479.00 |
| % from 52W High | -14.95% | -19.60% |
| All-Time High | ₹349.90 (Aug 17, 2020) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -63.83% | -19.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.40% | 0.10% |
| Quarterly Earnings Growth | -0.62% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.30% |
| Operating Margin (TTM) | 0.06% | 0.40% |
| Return on Equity (TTM) | 0.09% | 0.20% |
| Debt to Equity (MRQ) | 0.00 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹137.61 | ₹24.29 |
| Cash per Share (MRQ) | ₹26.45 | ₹0.92 |
| Operating Cash Flow (TTM) | ₹112.96M | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹124.07M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.84% | 0.17% |
| Last 12-Month Dividend | ₹5.50 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Tyche Industries Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | TYCHE (Apr 26, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.41 | 73.73 |
| Forward P/E | 21.18 | N/A |
| PEG Ratio | -0.30 | -17.55 |
| Price to Sales (TTM) | 2.48 | 22.23 |
| Price to Book (MRQ) | 0.89 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹1.25B | ₹35.41B |
| Enterprise Value | ₹982.33M | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.94 | 22.65 |
| Enterprise to EBITDA | 27.30 | 52.76 |
| Risk & Other Metrics | ||
| Beta | 0.29 | -0.17 |
| Book Value per Share (MRQ) | ₹137.61 | ₹24.29 |
Financial Statements Comparison: Tyche Industries Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | TYCHE (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 654.71M | 1.51B |
| Cost of Goods Sold | 363.99M | 318.78M |
| COGS % of Revenue | 55.6% | 21.1% |
| Gross Profit | 290.72M | 1.19B |
| Gross Margin | 44.4% | 78.9% |
| Research & Development | N/A | 34.37M |
| Operating Income (EBIT) | 100.29M | 642.49M |
| Operating Margin | 15.3% | 42.6% |
| EBITDA | 186.80M | 713.04M |
| EBITDA Margin | 28.5% | 47.3% |
| Pre-Tax Income | 167.14M | 655.38M |
| Pre-Tax Income % of Revenue | 25.5% | 43.5% |
| Income Tax | 43.07M | 167.66M |
| Income Tax % of Revenue | 6.6% | 11.1% |
| Net Income (Profit) | 124.07M | 487.72M |
| Profit Margin | 19.0% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | TYCHE (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 39.77M | 116.94M |
| Total Current Assets | 1.21B | 519.73M |
| Total Current Assets % of Revenue | 184.7% | 34.5% |
| Total Current Liabilities | 96.25M | 205.60M |
| Total Current Liabilities % of Revenue | 14.7% | 13.6% |
| Long-Term Debt | 0 | 296.36M |
| Long-Term Debt % of Revenue | 0.0% | 19.7% |
| Total Shareholders Equity | 1.37B | 2.48B |
| Retained Earnings | 1.19B | 2.37B |
| Retained Earnings % of Revenue | 181.5% | 157.4% |
| Property, Plant & Equipment | 68.16M | 411.30M |
Cash Flow Statement Comparison
| Metric | TYCHE (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | 112.96M | 970.68M |
| Operating Cash Flow % of Revenue | 17.3% | 64.4% |
| Capital Expenditures | -7.23M | -1.16B |
| Free Cash Flow | 78.21M | -251.22M |
| FCF Margin | 11.9% | -16.7% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TYCHE | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 10.25M | 108.97M |
| Float Shares | 2.93M | 29.52M |
| % Held by Insiders | 71.44% | 71.98% |
| % Held by Institutions | 0.00% | 1.18% |
| % Held by Public | 28.56% | 26.84% |
Dividend Analysis & Yield Comparison: Tyche Industries Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | TYCHE | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | ₹5.50 | ₹0.67 |
| Last 12-Month Dividend Yield | 3.84% | 0.17% |
| 3-Year Avg Annual Dividend | ₹3.00 | ₹0.22 |
| 3-Year Avg Dividend Yield | 1.41% | 0.17% |
| 3-Year Total Dividends | ₹9.00 | ₹0.67 |
| Ex-Dividend Date | Sep 19, 2025 | Sep 04, 2025 |